BridgeMD
New treatment option for Major Neurocognitive Disorder
Official title Exergaming Revolution in Dementia
ClinicalTrials.gov ID: NCT06631742
What this study is testing
- What it's testing
- This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the...
- Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30
You likely can't join if
- MMSE \<5
- Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the...
- Planned transfer to another facility within the next 3 months
- Acute behavioural problems
The study team makes the final eligibility decision.
Where it's taking place
- Wetzikon, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wetzikon, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.